Skip to content

Magis Pharma Group: what changed

BE 0765.834.004NACE 64.210, Activities of holding companiesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€399,056
2024 · -€9.4m+€9.0m
Equity
€530,028
2024 · €929,084-€399,056
Cash
€11,511
2024 · €84,762-€73,251
Balance sheet total
€13.0m
2024 · €11.2m+€1.8m

Largest movements

2024 to 2025
Assets
  • Receivables after one year +€1.3m

    up €1.3m (+74.4%), from €1.8m to €3.1m

    of which Other amounts receivable: +€1.3m

  • Receivables within one year +€590,134

    up €590,134 (+15.0%), from €3.9m to €4.5m

    of which Other amounts receivable: +€681,709

Equity and liabilities
  • Other debts +€1.4m

    up €1.4m (+176%), from €798,240 to €2.2m

  • Debts after one year +€1.0m

    up €1.0m (+12.4%), from €8.4m to €9.4m

  • Profit (loss) carried forward -€399,056

    down €399,056 (-4.3%), from -€9.4m to -€9.8m

  • Accrued charges and deferred income -€224,820

    down €224,820 (-100%), from €224,820 to €0

Income statement
  • Financial income -€204,637

    down €204,637 (-36.1%), from €567,257 to €362,620

  • Services and other goods +€159,645

    up €159,645 (+18.4%), from €868,068 to €1.0m

  • Financial charges +€148,302

    up €148,302 (+33.4%), from €443,729 to €592,031

  • Other operating charges -€29,269

    down €29,269 (-98.8%), from €29,636 to €368

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€9.4m
Turnover +€3,400
Services and other goods -€159,645
Depreciation -€421
Other operating charges +€29,269
Other operating items +€9.5m
Financial income -€204,637
Financial charges -€148,302
Result 2025 -€399,056
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€1.1m
Investment €0
Financing +€1.0m
Cash 2024 €84,762
Net result for the year -€399,056
Depreciation +€10,051
Receivables after one year -€1.3m
Receivables within one year -€590,134
Deferred charges and accrued income +€4,137
Trade debts -€8,647
Tax, wage and social debts -€1,281
Other debts +€1.4m
Accrued charges and deferred income -€224,820
Debts after one year +€1.0m
Cash 2025 €11,511
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2024 2025 Change %
Total assets 20/58 €11,177,973 €12,989,167 +€1.8m +16.2%
Fixed assets 21/28 €5,409,559 €5,399,508 -€10,051 -0.2%
Intangible fixed assets 21 €35,085 €25,034 -€10,051 -28.6%
Financial fixed assets 28 €5,374,474 €5,374,474 = 0.0%
Affiliated companies 280/1 €5,374,474 €5,374,474 = 0.0%
Participating interests 280 €5,374,474 €5,374,474 = 0.0%
Current assets 29/58 €5,768,414 €7,589,659 +€1.8m +31.6%
Amounts receivable after more than one year 29 €1,757,755 €3,066,255 +€1.3m +74.4%
Trade receivables 290 €0 - =
Other amounts receivable 291 €1,757,755 €3,066,255 +€1.3m +74.4%
Stocks and contracts in progress 3 €0 €0 =
Amounts receivable within one year 40/41 €3,921,761 €4,511,894 +€590,134 +15.0%
Trade receivables 40 €205,007 €113,432 -€91,575 -44.7%
Other amounts receivable 41 €3,716,754 €4,398,462 +€681,709 +18.3%
Cash at bank and in hand 54/58 €84,762 €11,511 -€73,251 -86.4%
Deferred charges and accrued income 490/1 €4,137 €0 -€4,137 -100%
Total equity and liabilities 10/49 €11,177,973 €12,989,167 +€1.8m +16.2%
Equity 10/15 €929,084 €530,028 -€399,056 -43.0%
Contributions 10/11 €10,252,489 €10,252,489 = 0.0%
Revaluation surpluses 12 €28,154 €28,154 = 0.0%
Profit (loss) carried forward 14 -€9,351,559 -€9,750,615 -€399,056 -4.3%
Amounts payable 17/49 €10,248,889 €12,459,139 +€2.2m +21.6%
Amounts payable after more than one year 17 €8,380,000 €9,421,734 +€1.0m +12.4%
Financial debts 170/4 €8,380,000 €9,421,734 +€1.0m +12.4%
Other loans 174 €8,380,000 €9,421,734 +€1.0m +12.4%
Amounts payable within one year 42/48 €1,644,069 €3,037,405 +€1.4m +84.7%
Trade debts 44 €843,087 €834,440 -€8,647 -1.0%
Suppliers 440/4 €843,087 €834,440 -€8,647 -1.0%
Taxes, remuneration and social security 45 €2,742 €1,461 -€1,281 -46.7%
Taxes 450/3 €2,742 €1,461 -€1,281 -46.7%
Other amounts payable 47/48 €798,240 €2,201,504 +€1.4m +176%
Accrued charges and deferred income 492/3 €224,820 €0 -€224,820 -100%
Operating income 70/76A €865,088 €868,488 +€3,400 +0.4%
Turnover 70 €865,088 €868,488 +€3,400 +0.4%
Operating charges 60/66A €10,427,151 €1,038,132 -€9.4m -90.0%
Services and other goods 61 €868,068 €1,027,714 +€159,645 +18.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,631 €10,051 +€421 +4.4%
Other operating charges 640/8 €29,636 €368 -€29,269 -98.8%
Non-recurring operating charges 66A €9,519,816 €0 -€9.5m -100%
Operating profit (loss) 9901 -€9,562,063 -€169,644 +€9.4m +98.2%
Financial income 75/76B €567,257 €362,620 -€204,637 -36.1%
Recurring financial income 75 €567,257 €362,620 -€204,637 -36.1%
Income from financial fixed assets 750 €567,257 €362,620 -€204,637 -36.1%
Financial charges 65/66B €443,729 €592,031 +€148,302 +33.4%
Recurring financial charges 65 €443,729 €592,031 +€148,302 +33.4%
Debt charges 650 €442,819 €588,237 +€145,418 +32.8%
Other financial charges 652/9 €910 €3,794 +€2,884 +317%
Profit (loss) for the period before taxes 9903 -€9,438,535 -€399,056 +€9.0m +95.8%
Profit (loss) for the period 9904 -€9,438,535 -€399,056 +€9.0m +95.8%
Profit (loss) for the period to be appropriated 9905 -€9,438,535 -€399,056 +€9.0m +95.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

For holding and financial companies, the adjusted equity is usually a better measure than the earnings. Give the capitalised earnings a lower weight then.

Indicative value of the equity

Indication, not a valuation or advice
€504,994 to €504,994

Midpoint €504,994 · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €504,994
Indication €504,994

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€530,028
Intangible fixed assets (21)
-€25,034
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€504,994

Capitalised earnings

net result for the year (9904)
2025
-€399,056
2024
-€9,438,535
excluding non-recurring income and charges
€81,280
2023
-€137,986
2022
€456,247
2021
-€231,284
Average result, excluding non-recurring income and charges
-€151,921
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.